Effect of Sodium Hyaluronate intra-articular injection on both synovial fluid and plasma interleukin-17 of patients with knee osteoarthritis
BAI Yuming1 ZHANG Haisen1 LIU Chang1 JIN Shengli1 SU Ke1 LIU Ying2 LYU Zhichang3
1.The Sencod Department of Orthopaedics Surgery, Central Hospital of Cangzhou, Hebei Province, Cangzhou 061001, China;
2.Operation Room, People′s Hospital of Cangzhou, Hebei Province, Cangzhou 061001, China;
3.Derpatment of Orthopaedics Surgery, People′s Hospital of Xian County, Hebei Province, Xian County 062250, China
Abstract：Objective To discuss the changes of interleukin-17 (IL-17) levels in both synovial fluid and plasm of patients with primary knee osteoarthritis (OA) after intra-articular injection of Sodium Hyaluronate. Methods 56 patients with primary knee OA given intra-articular injection of Sodium Hyaluronate in Central Hospital of Cangzhou from January 2013 to January 2016 (experimental group) and 30 healthy individuals (control group) were recruited into the study. There were no significant differences in gender, age, and body mass index between the two groups (P > 0.05). Visual analogue scale (VAS) was used to evaluate the pain level of the patients. The IL-17 concentrations in both plasma and synovial fluid were measured before intra-articular injection of Sodium Hyaluronate and at 1, 4, 8, 12 weeks after injection in the experimental group. The IL-17 levels in plasma were measured in the control group. The IL-17 levels were determined using ELISA method. Results Average VAS scores within 8 weeks after the injection were substantially lower than pre-injection periods (P < 0.05) in the experimental group. Average VAS pain score at 12 weeks after intra-articular injection of Sodium Hyaluronate was not statistically significant in comparison with pre-injection period (P > 0.05). Average plasm IL-17 concentration in the control group was (2.4±1.7) pg/mL. OA patients before the injection had higher plasma IL-17 concentration compared to the control group (P < 0.05). Average IL-17 levels in both synovial fluid and plasm at each time point for patients with OA within 8 weeks after the injection were significant lower than pre-injection periods (P < 0.05), but IL-17 levels in plasma were higher than controls (P < 0.05). Average IL-17 levels in both synovial fluid and plasm at 12 weeks after the injection were not statistically significant in comparison with pre-injection periods (P > 0.05). Conclusion For the patients with knee OA, pain symptoms have significantly been improved and IL-17 levels in both synovial fluid and plasm reduced within 8 weeks after intra-articular injection of Sodium Hyaluronate. After 12 weeks, the clinical curative effect has disappearenced, IL-17 levels in both synovial fluid and plasm are restored to the level before treatment.
白玉明1 张海森1 刘畅1 靳胜利1 苏柯1 刘颖2 吕志昌3. 玻璃酸钠关节腔注射对膝骨关节炎患者关节液及血浆中白介素-17的影响[J]. 中国医药导报, 2017, 14(19): 118-121.
BAI Yuming1 ZHANG Haisen1 LIU Chang1 JIN Shengli1 SU Ke1 LIU Ying2 LYU Zhichang3. Effect of Sodium Hyaluronate intra-articular injection on both synovial fluid and plasma interleukin-17 of patients with knee osteoarthritis. 中国医药导报, 2017, 14(19): 118-121.
[1] Cooper BG，Stewart RC，Burstein D，et al. A Tissue-Penetrating Double Network Restores the Mechanical Properties of Degenerated Articular Cartilage [J]. Angew Chem Int Ed Engl，2016，55（13）：4226-4230.
[2] Honsawek S，Deepaisarnsakul B，Tanavalee A，et al. Association of the IL-6 -174G/C gene polymorphism with knee osteoarthritis in a Thai population [J]. Genet Mol Res，2011， 10（3）：1674-1680.
[3] Hulin-Curtis SL，Bidwell JL，Perry MJ. Evaluation of IL18 and IL18R1 polymorphisms：genetic susceptibility to knee osteoarthritis [J]. Int J Immunogenet，2012，39（2）：106-109.
[4] 张海森，白玉明，靳胜利，等.白细胞介素-17基因多态性与骨关节炎易感性之间的相关性研究[J].中华骨科杂志，2016，36（22）：1450-1455.
[5] 张海森，白玉明，刘畅，等.血清及滑液白介素-17水平与膝骨关节炎退变及膝痛程度的相关性研究[J].中国医药导报，2016，13（33）：84-87.
[6] Kan JI，Mishima S，Kashiwakura JI，et al. Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis [J]. Allergol Int，2016，65（Suppl）：S11-S16.
[7] Murphy EP，Curtin M，Mcgoldrick NP，et al. Prospective Evaluation of Intra-Articular Sodium Hyaluronate Injection in the Ankle [J]. J Foot Ankle Surg，2017，56（2）：327-331.
[8] Suzigan EM. Poster 133 Analysis of Pain and Functionality in Knee Osteoarthritis Patients after Sodium Hyaluronate Viscosupplementation [J]. Rheumatology（Oxford），2016，8（9）：S205-S205.
[9] Xin Y，Jianhao L，Tiansheng S，et al. The efficacy and safety of sodium hyaluronate injection（AdantR）in treating degenerative osteoarthritis：a multi-center，randomized，double-blind，positive-drug parallel-controlled and non-inferiority clinical study [J]. Int J Rheum Dis，2015，19（3）：271-278.
[10] Bannuru RR，Brodie CR，Sullivan MC，et al. Safety of Repeated Injections of Sodium Hyaluronate（SUPARTZ）for Knee Osteoarthritis：A Systematic Review and Meta-Analysis [J]. Cartilage，2016，7（4）：322.
[11] Xie W，Cheng B，Orthopedics DO. The effect of medical ozone combined with sodium hyaluronate injection in the treatment of the knee osteoarthritis after arthroscopic surgery [J]. J Bengbu Med Coll，2015，13（3）：327-338.
[12] Altman RD. Criteria for the classification of osteoarthritis of the knee and hip [J]. Scand J Rheumatol，1987，65（Supp 65）：31-39.
[13] Oudenaarde KV，Jobke B，Oostveen ACM，et al. Predictive value of MRI features for development of radiographic osteoarthritis in a cohort of participants with pre-radiographic knee osteoarthritis-the CHECK study [J]. Rheumatology，2017，56（1）：113-120.
[14] Karabis A，Nikolakopoulos S，Pandhi S，et al. High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis：meta-analysis and implications [J]. Arthritis Res Ther，2016，18（1）：1-7.
[15] Bondeson J，Wainwright SD，Lauder S，et al. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases，matrix metalloproteinases，and other destructive and inflammatory responses in osteoarthritis [J]. Arthritis Res Ther，2006，8（6）：R187.
[16] Wu X，Kondragunta V，Kornman KS，et al. IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort [J]. Osteoarthritis Cartilage，2013，21（7）：930-938.
[17] Chen L，Li DQ，Zhong J，et al. IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis [J]. Osteoarthritis Cartilage，2011，19（6）：711-718.
[18] Wang K，Xu J，Cai J，et al. Plasm levels of interleukin-17 and adiponectin are associated with infrapatellar fat pad volume and signal intensity alteration in patients with knee osteoarthritis [J]. Arthritis Res Ther，2016，18（1）：193.
[19] Deligne C，Casulli S，Pigenet A，et al. Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients [J]. Osteoarthritis Cartilage，2015，23（11）：1843-1852.
[20] Wang K，Xu J，Cai J，et al. Plasm levels of resistin and interleukin-17 are associated with increased cartilage defects and bone marrow lesions in patients with knee osteoarthritis [J]. Mod Rheumatol，2017，27（2）：339-344.
[21] 林福长，黄班华，黄魏翔，等.全髋关节置换术治疗老年髋关节发育不良继发骨关节炎患者的临床研究[J].中国医药科学，2016，6（17）：186-188，197.
[22] Yang L，Zhang J，Wang G. The effect of sodium hyaluronate treating knee osteoarthritis on synovial fluid interleukin -1β and clinical treatment mechanism [J]. Pak J Pharm Sci，2015，28（1 Suppl）：407.
[23] 乔良胜，焦尚起，王硕，等.关节置换手术年龄时机选择对老年膝关节退行性骨关节炎疗效的影响[J].疑难病杂志，2014，13（10）：1019-1021.DOI：10.3969/j.issn.1671-6450.2014.10.009.
[24] 高峰.血清及滑液中CCL13的水平与膝关节骨关节炎放射学之间的关系[J].中国医药科学，2015，5（16）：33-35，59.
2017, Vol. 14 
京公网安备 11010502046598号